Chiropractic Rehabilitation and Your Wellness Using Omega-3s

Learn how omega-3s and chiropractic rehabilitation can support your recovery and promote a healthier lifestyle.

Abstract

In this educational post, we explore how omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), resolve inflammation rather than suppress it. It is grounded in the latest evidence-based research from leading investigators. It describes the physiological pathways through which these vital nutrients produce specialized pro-resolving mediators (SPMs) such as resolvins, protectins, and maresins. They clear inflammatory cells, restore tissue homeostasis, and help healing in multiple body systems. The post also discusses dietary and supplemental sources, systemic benefits for cardiovascular, neurological, joint, and immune health, and the synergistic benefits with integrative chiropractic care. Chiropractic adjustments modulate neuro-immune responses, reduce pain, and improve recovery in non-surgical settings. Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST of Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, works with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933) as Medical Director and Collaborative Physician with over 40 years of experience. The multidisciplinary team utilizes biomechanics, medicine, nutrition, functional medicine, personal injury care, and rehabilitation to treat pain, discomfort, and chronic inflammation. Readers will come away with a clear, narrative understanding of how these approaches can build a practical, evidence-informed health and wellness routine.

How Omega-3 Fatty Acids Actively Resolve Inflammation and Support Whole-Body Healing

Omega-3 polyunsaturated fatty acids (PUFAs) are vital nutrients the human body does not synthesize in adequate amounts and must obtain from food or supplements. The major long-chain forms, EPA and DHA, are incorporated into cell membranes throughout the body and influence membrane fluidity, receptor signaling, and the production of bioactive lipid mediators. Omega-3s are not classical anti-inflammatory agents that block enzymes like cyclooxygenase and shut down the entire inflammatory cascade, but they are substrates for an active resolution program. In response to cell injury or infection, a highly regulated switch in lipid mediators is initiated. SPMs replace early pro-inflammatory eicosanoids from arachidonic acid. Lipoxygenase and cyclooxygenase enzymes mediate this switch by acting on EPA and DHA stored in membrane phospholipids. The resolvins (E-series from EPA, D-series from DHA), protectins, and maresins produced bind to specific G-protein-coupled receptors on immune cells, enhancing efferocytosis (phagocytosis of apoptotic cells) to promote neutrophil clearance, reduce further leukocyte recruitment, and stimulate tissue regeneration. Recent preclinical studies show that prophylactic omega-3 enrichment reduces arthritis severity, associated with suppression of non-classical monocytes and VCAM-1-positive synovial fibroblasts, and an increase in MerTK-positive, CD206-positive pro-resolving macrophages. Lipidomics of affected tissues identified elevated resolvin E2 and resolvin E4. Pharmacologic administration of these same resolvins recapitulates the protective phenotype, confirming that it is the mediators themselves and not just reduced substrate competition that drive resolution. Similar studies in models of neuroinflammation show that DHA supplementation increases resolvin D1 levels in brain tissue and serum, restores glutathione peroxidase activity, and decreases malondialdehyde, a marker of oxidative damage. Findings in journals such as Communications Biology and other neuroscience publications explain why blocking inflammation alone is not enough; the body needs the helpful signals that SPMs send to complete healing.

Dietary Sources and Supplemental Forms of Omega-3 Fatty Acids That Optimize Resolution Pathways

In humans, plant-derived alpha-linolenic acid converts inefficiently to EPA and DHA, so marine sources remain the most efficient way to raise tissue levels. Cold-water fatty fish such as salmon, mackerel, sardines, herring, and anchovies contain preformed EPA and DHA, bound as phospholipids or triglycerides. For those who don’t regularly eat fish, concentrated doses are available in high-quality fish oil concentrates, krill oil (which also contains the antioxidant astaxanthin) and algal oil (suitable for vegetarians). Typical therapeutic doses are in the range of 1 to 4 grams of combined EPA plus DHA per day, with higher pure EPA preparations (eg, 4 grams of icosapent ethyl) used in some clinical trials. Algal sources have been considered for their sustainability and high DHA content, which is relevant for neural tissues. Consistency is key: incorporation into erythrocyte membranes, as measured by the omega-3 index, increases over weeks to months. The precursors 18-HEPE and 17-HDHA that feed SPM synthesis increase reliably with supplementation. At Injury Medical Clinic PA, we always start with food in clinical practice and supplement with purified oils if dietary intake is insufficient. We do this under medical supervision, with attention to compatibility with other medications and laboratory monitoring of lipid profiles and inflammatory markers.

Systemic Benefits of Omega-3s for Cardiovascular, Neurological, Musculoskeletal, and Oncologic Health

Higher EPA and DHA status is associated with lower circulating triglycerides, improved endothelial function, reduced platelet aggregation, and favorable changes in the omega-6 to omega-3 ratio that limit excessive production of pro-inflammatory prostaglandins and leukotrienes. Meta-analyses of randomized trials and large prospective cohorts consistently show that moderate intakes of higher blood levels or dietary intake are associated with reduced risk of coronary events, ischemic stroke, and in some analyses, atrial fibrillation. DHA is a major structural component of neuronal membranes in the brain and promotes synaptic plasticity, neurotrophic signaling, and generation of neuroprotectin D1, which inhibits microglial activation. Observational data suggest that higher seafood intake is associated with slower cognitive decline. At the same time, interventional trials have yielded more variable cognitive outcomes, but subgroup analyses indicate benefit in carriers of the APOE4 allele. Recent work shows that DHA can increase brain omega-3 levels even when cognitive scores are stable over 2 years. Joint tissue is no different. A meta-analysis of osteoarthritis trials found that omega-3 supplements reduce pain and improve function. Studies of rheumatoid arthritis found that they reduced the need for NSAIDs. A 2026 Communications Biology investigation also showed that feeding Omega-3 modulated joint cell phenotypes toward resolution via E-series resolvins. The phase 3 EMT2 trial presented at the 2026 European Society for Medical Oncology Congress was especially notable. Patients scheduled for surgery for removal of liver metastases of colorectal cancer were randomized to receive high-purity EPA 4 g/day or placebo beginning before surgery and continuing for two to four years. At five years, overall survival was 62 percent for EPA and 45.1 percent for placebo (hazard ratio, 0.68; p = .03), although progression-free survival did not differ significantly. Researchers suggested mechanisms including anti-cachexia effects, enhanced antitumor immunity, and favorable gut-microbiome shifts. These findings are consistent with previous reports that fish-oil supplementation may improve performance status during chemotherapy in gastrointestinal cancers and increase response rates in advanced non-small-cell lung cancer. In orthopedics, omega-3s have been shown to promote synthesis of the cartilage matrix, alter bone turnover, and hasten resolution of post-traumatic inflammation, providing a biochemical substratum for coupling with mechanical interventions.

Chiropractic Care Mechanisms That Reduce Pain and Modulate Inflammatory Mediators

Chiropractic spinal manipulative therapy is a high-velocity, low-amplitude thrust that stimulates mechanoreceptors in the paraspinal tissues and joint capsules. Large-diameter afferent signals reach the dorsal horn, where they can produce segmental inhibition of nociceptive transmission, reduce central sensitization, and influence descending pain-modulatory pathways from the periaqueductal gray. Targeted changes in animal models of intervertebral foramen inflammation reduce the duration of thermal and mechanical hyperalgesia, normalize dorsal root ganglion excitability, and accelerate histologic resolution of local inflammation. Human trials report decreases in circulating or ex vivo production of tumor necrosis factor-alpha, interleukin-6, and interferon-gamma after short courses of lumbar or thoracic manipulation in patients with acute or chronic low-back pain. In a pragmatic 12-week randomized trial published in 2025, chiropractic care increased brain-derived neurotrophic factor and decreased tumor necrosis factor-alpha compared with sham, consistent with increased neuroplasticity and regulated inflammatory tone. These neuroimmune effects are not merely a result of biomechanical realignment, but rather of improved segmental motion, decreased aberrant afferent barrage, and consequent normalization of autonomic and immune set-points. Furthermore, it is a natural fit for integrative protocols that also address systemic drivers of inflammation because it is non-surgical and low risk when used appropriately.

Synergistic Effects of Combining Omega-3 Supplementation with Chiropractic Care for Pain and Recovery

When membrane stores of EPA and DHA are replete, the same mechanical stimuli that activate local resolution programs can more readily generate SPMs at the site of joint or soft-tissue injury. These changes support burden-resolution pathways by reducing pro-inflammatory cytokine production, and SPMs accelerate macrophage phenotype switching and tissue remodeling. In the clinical setting, patients treated with nutritional optimization and spinal care tend to have a faster decrease in pain scores, a quicker return of range of motion, and fewer flare-ups during rehabilitation. The rationale is simple: mechanical correction removes the ongoing nociceptive and inflammatory drive from restricted segments or myofascial tension, while omega-3-derived mediators provide molecular signals that terminate the residual inflammatory response and promote regeneration. For patients with chronic musculoskeletal pain, stiffness after injury, or inflammatory arthropathies, the combination addresses both the structural and biochemical aspects of the problem. This dual approach in personal-injury and sports-rehabilitation settings supports documentation of progressive functional improvement while minimizing reliance on pharmacologic anti-inflammatories that can delay true resolution.

The Healing Diet: Combat Inflammation, Embrace Wellness- Video

Integrative Multidisciplinary Care at Injury Medical Clinic PA Under Medical Direction

Injury Medical Clinic PA, or Mission Plaza Injury Medical Clinic, is a partnership practice in El Paso, TX. Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, offers chiropractic evaluation and treatment, nurse practitioner medical assessment, functional medicine interpretation of laboratory data, and coordinated rehabilitation planning. Medical Director and Collaborative Physician: Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933). She has over 40 years of experience as an internist and provides physician-level oversight of complex medical comorbidities, medication reconciliation, and overall medical direction of care. This is a common setup in modern integrative and injury clinics, where the chiropractor focuses on the biomechanical and neuromusculoskeletal aspects. At the same time, the internist ensures medical safety, manages systemic disease, and co-manages conditions that may affect recovery. Additional team members provide expertise in personal-injury documentation, physical rehabilitation, nutritional counseling, and performance conditioning. As a result, patients receive a single coordinated plan that may include spinal adjustments, soft-tissue therapies, targeted omega-3 repletion, laboratory monitoring of inflammatory markers and fatty-acid profiles, and progressive exercise. The model reduces care fragmentation and lets clinical observations (e.g., faster resolution of post-traumatic inflammation when nutritional status is optimized) drive ongoing protocol refinement.

Practical Steps for Incorporating Omega-3s and Chiropractic Care into a Health and Wellness Routine

Start with a dietary assessment aiming for two to three servings of fatty fish per week or an equivalent algal or fish oil supplement with at least 1 gram of combined EPA plus DHA. Cut back on excess omega-6 from refined seed oils so resolution pathways aren’t inhibited by competition. Schedule an evaluation with a chiropractor experienced in integrative care to identify segmental restrictions, myofascial contributors, and movement patterns that perpetuate pain. During the acute or subacute phase, treatment frequency is usually higher (two to three visits per week), tapering to maintenance once objective improvement in pain, range of motion, and inflammatory biomarkers is documented. Laboratory monitoring (complete blood count, high-sensitivity C-reactive protein, omega-3 index, and relevant metabolic panels) is done concurrently to guide dose adjustments and confirm safety under medical supervision. Rehabilitation exercises restore motor control and endurance, and lifestyle factors such as sleep, stress management, and moderate physical activity further support SPM generation and neuroimmune balance. The multidisciplinary team can refine the plan by prompting patients to track symptoms, functional milestones, and changes in medication needs. Both are low-risk interventions when properly indicated and monitored, and can be continued as part of long-term wellness rather than used only for crisis management.

Clinical Observations and Evidence-Informed Practice Insights

In the clinic, patients with chronic neck or low-back pain following motor vehicle accidents or repetitive strain often have high levels of inflammatory markers and low omega-3 indices. Many report earlier decreases in morning stiffness and better tolerance for rehabilitative loading when spinal care is combined with supervised EPA/DHA repletion. Recent EMT2 trial data on overall survival in advanced colorectal cancer further underscore the broader physiologic impact of high-dose EPA and the value of targeting systemic inflammation, even in patients whose primary complaint is musculoskeletal issues. These observations align with published mechanistic studies showing that both nutritional and manipulative interventions can simultaneously modulate cytokine production. Ongoing outcome documentation refines protocols within the collaborative medical framework that Dr. Cardenas and the clinic team provide.

Conclusion

Omega-3 fatty acids provide the molecular substrate for the active resolution of inflammation through specialized pro-resolving mediators, while chiropractic care reduces nociceptive drive and modulates neuroimmune signaling. They provide a non-surgical, evidence-informed approach for pain and discomfort. Injury Medical Clinic PA in El Paso integrates chiropractic, internal medicine under the supervision of Dr. Maria Guadalupe Cardenas, MD, functional medicine, and rehabilitation to give you real options to incorporate into your daily health routine. Readers are encouraged to talk with qualified providers about individualized plans, understanding that lasting inflammation resolution is key to recovery from injury and long-term wellness.

References

• Omega-3 PUFA supplementation promotes arthritis resolution by modulating joint cell phenotype involving E-series resolvins. (2026). Communications Biology.
• Effects of Docosahexaenoic Acid (DHA) on oxidative stress parameters, inflammation, and resolvin D1 expression in a mouse model of neuroinflammation. (2026). IP Indian Journal of Neurosciences.
• Brooks, M. (2026, October 28). Can omega-3 supplements prolong life in metastatic CRC?. Medscape.
• Phase 3 EMT2 trial demonstrates survival benefit for high-dose EPA. (2026, October 26). News-Medical.
• Thompson, D. (2026, October 30). Omega-3s might improve survival in advanced cancer, trial finds. MedicineNet.
• The effects of 12 weeks of chiropractic spinal adjustments on physiological biomarkers in adults: A pragmatic randomized controlled trial. (2025). PLOS One.
• Effects of spinal manipulative therapy on inflammatory mediators in patients with non-specific low back pain. (2021). Chiropractic & Manual Therapies.
• Gevers-Montoro, C., et al. (2021). Neurophysiological mechanisms of chiropractic spinal manipulation for spine pain. European Journal of Pain.
• Beneficial effects of omega-3 fatty acids on obesity and related metabolic and chronic inflammatory diseases. (2025). Nutrients.
• Additional foundational reviews on SPM biosynthesis and clinical applications appear in Current Atherosclerosis Reports, Nutrition Reviews, and related peer-reviewed sources.

SEO Tags

omega-3 fatty acids, EPA, DHA, inflammation resolution, specialized pro-resolving mediators resolvins, chiropractic care pain reduction, integrative non-surgical treatment, El Paso, Dr Alexander Jimenez DC, Dr Maria Guadalupe Cardenas MD, Injury Medical Clinic PA, omega-3 supplements benefits, musculoskeletal healing, omega-3, chiropractic, functional medicine, inflammation, personal injury rehabilitation El Paso, evidence-based omega-3 research 2026, spinal manipulative therapy, cytokines, health wellness routine

Disclaimer: This post is intended for educational purposes and does not constitute personalized medical advice. Consult qualified healthcare providers before beginning any new supplement or treatment regimen.